Anti-RSV F/Fusion glycoprotein F0 Reference Antibody (R4.C6)

Description: Anti-RSV F/Fusion glycoprotein F0 (R4.C6) (BS11352) is a research-grade recombinant antibody targeting F. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG1
Species reactivity: HumanrespiratorysyncytialvirusA(strainA2)
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: F,FusionglycoproteinF0,FusionglycoproteinF2,p27,Interveningsegment,Pep27,Peptide27,FusionglycoproteinF1
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Fusion glycoprotein F0 is a ~63 kDa protein. Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.
Note: For research use only. Not suitable for clinical or therapeutic use.